Arcutis Biotherapeutics (ARQT)
(Real Time Quote from BATS)
$9.73 USD
-0.42 (-4.14%)
Updated Sep 23, 2024 12:00 PM ET
3-Hold of 5 3
F Value C Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/1/24 |
---|---|
Current Quarter | -0.40 |
EPS Last Quarter | -0.42 |
Last EPS Surprise | 12.50% |
ABR | 1.43 |
Earnings ESP
|
-4.13% |
---|---|
Current Year | -1.56 |
Next Year | -1.18 |
EPS (TTM) | -2.19 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 41.14M | 53.19M | 160.93M | 243.19M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 43.17M | 58.87M | 182.47M | 280.77M |
Low Estimate | 39.10M | 47.50M | 139.40M | 205.60M |
Year ago Sales | 38.11M | 13.53M | 59.61M | 160.93M |
Year over Year Growth Est. | 7.94% | 293.09% | 170.00% | 51.11% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.40 | -0.36 | -1.56 | -1.18 |
# of Estimates | 3 | 2 | 3 | 3 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.39 | -0.35 | -1.49 | -1.15 |
Low Estimate | -0.42 | -0.36 | -1.70 | -1.23 |
Year ago EPS | -0.73 | -0.72 | -3.78 | -1.56 |
Year over Year Growth Est. | 45.21% | 50.00% | 58.73% | 24.78% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 2 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.40 | -0.36 | -1.56 | -1.18 |
7 Days Ago | -0.40 | -0.36 | -1.56 | -1.18 |
30 Days Ago | -0.40 | -0.35 | -1.50 | -1.19 |
60 Days Ago | -0.41 | -0.40 | -1.60 | -1.14 |
90 Days Ago | -0.41 | -0.40 | -1.60 | -1.14 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.42 | -0.36 | -1.70 | -1.15 |
Zacks Consensus Estimate | -0.40 | -0.36 | -1.56 | -1.18 |
Earnings ESP | -4.13% | -1.41% | -8.74% | 2.27% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.42 | -0.32 | -0.72 | -0.73 | NA |
Estimate | -0.48 | -0.60 | -0.65 | -0.90 | NA |
Difference | 0.06 | 0.28 | -0.07 | 0.17 | 0.11 |
Surprise | 12.50% | 46.67% | -10.77% | 18.89% | 16.82% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more